These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

699 related items for PubMed ID: 28516675

  • 21. How do I … manage the platelet transfusion-refractory patient?
    Juskewitch JE, Norgan AP, De Goey SR, Duellman PM, Wakefield LL, Gandhi MJ, Stubbs JR, Kreuter JD.
    Transfusion; 2017 Dec; 57(12):2828-2835. PubMed ID: 28960321
    [Abstract] [Full Text] [Related]

  • 22. Use of HLA- and HPA--matched platelets in alloimmunized patients.
    Kekomäki R.
    Vox Sang; 1998 Dec; 74 Suppl 2():359-63. PubMed ID: 9704468
    [Abstract] [Full Text] [Related]

  • 23. Comparison of the bead-based simultaneous analysis of specific platelet antibodies assay (SASPA) and Pak Lx Luminex technology with the monoclonal antibody immobilization of platelet antigens assay (MAIPA) to detect platelet alloantibodies.
    Rockenbauer L, Eichelberger B, Panzer S.
    Clin Chem Lab Med; 2015 Oct; 53(11):1779-83. PubMed ID: 25781691
    [Abstract] [Full Text] [Related]

  • 24. Slot blotting and flow cytometry: two efficient assays for platelet antibody screening among patients with platelet refractoriness.
    Ameri Z, Vahidi R, Khaleghi M, Dehesh T, Sheikhbardsiri A, Farsinejad A.
    Vox Sang; 2021 Jan; 116(1):106-115. PubMed ID: 32770852
    [Abstract] [Full Text] [Related]

  • 25. Rapid detection of HPA-1 alloantibodies by platelet antigens immobilized onto microbeads.
    Bakchoul T, Meyer O, Agaylan A, Bombard S, Bein G, Sachs UJ, Salama A, Santoso S.
    Transfusion; 2007 Aug; 47(8):1363-8. PubMed ID: 17655579
    [Abstract] [Full Text] [Related]

  • 26. The detection of platelet antibodies by simultaneous analysis of specific platelet antibodies and the monoclonal antibody-specific immobilization of platelet antigens: an interlaboratory comparison.
    Nguyen XD, Goebel M, Schober M, Klüter H, Panzer S.
    Transfusion; 2010 Jul; 50(7):1429-34. PubMed ID: 20456677
    [Abstract] [Full Text] [Related]

  • 27. Successful treatment of platelet transfusion refractoriness: the use of platelet transfusions matched for both human leucocyte antigens (HLA) and human platelet alloantigens (HPA) in alloimmunized patients with leukaemia.
    Kekomäki S, Volin L, Koistinen P, Koivunen E, Koskimies S, Ruutu T, Timonen T, Kekomäki R.
    Eur J Haematol; 1998 Feb; 60(2):112-8. PubMed ID: 9508352
    [Abstract] [Full Text] [Related]

  • 28. [Analysis of transfusion effect of different platelet matching schemes in patients with platelet transfusion refractoriness].
    Liang YJ, Wang H, Zhao PZ, Wang F, Li Q, Xu Y, Wu YX, Zhang DM, He XH.
    Zhonghua Yi Xue Za Zhi; 2024 Mar 19; 104(11):865-869. PubMed ID: 38462363
    [Abstract] [Full Text] [Related]

  • 29. Report on the 19th International Society of Blood Transfusion Platelet Immunology Workshop 2018.
    Lewin A, Al Khan S, Beaudin L, Meilleur L, Clarke G, Richard L.
    Vox Sang; 2020 Nov 19; 115(8):767-782. PubMed ID: 32468604
    [Abstract] [Full Text] [Related]

  • 30. Post-transfusion purpura (PTP) associated with anti-HPA-1a, anti-HPA-2b and anti-HPA-3a antibodies.
    Lucas GF, Pittman SJ, Davies S, Solanki T, Brüggemann K.
    Transfus Med; 1997 Dec 19; 7(4):295-9. PubMed ID: 9510928
    [Abstract] [Full Text] [Related]

  • 31. Platelet refractoriness due to combined anti-HLA and anti-HPA-5a alloantibodies: clinical management during myeloablative allogeneic HSCT and development of a quantitative MAIPA assay.
    Arber C, Bertrand G, Halter J, Boehlen F, Kaplan C, Gratwohl A.
    Br J Haematol; 2007 Oct 19; 139(1):159-61. PubMed ID: 17854320
    [No Abstract] [Full Text] [Related]

  • 32. Anti-HLA alloantibodies in surgical patients refractory to platelet transfusion.
    Peña JR, Saidman SL, Girouard TC, Meister E, Dzik WH, Makar RS.
    Am J Hematol; 2014 Sep 19; 89(9):E133-7. PubMed ID: 24816643
    [Abstract] [Full Text] [Related]

  • 33. The first reported case of neonatal alloimmune thrombocytopenia due to low-frequency human platelet antigen-6b antibodies in the United Kingdom.
    Hopkins M, Brookes J, Watson D, Wroe E, Guthrie P, Horler J, Anayattil K, Calvert A, Poles A.
    Transfusion; 2021 Sep 19; 61(9):2788-2794. PubMed ID: 34156106
    [Abstract] [Full Text] [Related]

  • 34. Development of quantitative monoclonal antibody-specific immobilization of platelet antigens assay for antibodies against human platelet antigen-1a, 3a, and 5b.
    Li RS, Ling B, Lu P.
    Platelets; 2018 Jan 19; 29(1):71-75. PubMed ID: 28406722
    [Abstract] [Full Text] [Related]

  • 35. Diagnosis and treatment of immunological platelet refractoriness by histocompatibility.
    Fagundes IS, Franz JM, Jobim MS, Arend A, Merzoni J, Cardone JM, Gil B, Sekine L, Jobim LF.
    Hum Immunol; 2020 May 19; 81(5):197-201. PubMed ID: 32067841
    [Abstract] [Full Text] [Related]

  • 36. Anti-HLA Class I alloantibodies in platelet transfusion refractoriness: From mechanisms and determinants to therapeutic prospects.
    Couvidou A, Rojas-Jiménez G, Dupuis A, Maître B.
    Front Immunol; 2023 May 19; 14():1125367. PubMed ID: 36845153
    [Abstract] [Full Text] [Related]

  • 37. Strategies for managing refractoriness to platelet transfusions.
    Dan ME, Schiffer CA.
    Curr Hematol Rep; 2003 Mar 19; 2(2):158-64. PubMed ID: 12901147
    [Abstract] [Full Text] [Related]

  • 38. [An evaluation of platelet transfusion response using HLA crossmatch-compatible donors in patients with platelet refractoriness].
    Hyun J, Lim YM, Park KD, Han BY, Kim YH, Han KS, Park MH.
    Korean J Lab Med; 2009 Oct 19; 29(5):481-9. PubMed ID: 19893359
    [Abstract] [Full Text] [Related]

  • 39. Low-level HLA antibodies do not predict platelet transfusion failure in TRAP study participants.
    Jackman RP, Deng X, Bolgiano D, Lebedeva M, Heitman JW, Busch MP, Slichter SJ, Norris PJ.
    Blood; 2013 Apr 18; 121(16):3261-6; quiz 3299. PubMed ID: 23393051
    [Abstract] [Full Text] [Related]

  • 40. Platelet transfusion refractoriness associated with HPA-1a (Pl(A1)) alloantibody without coexistent HLA antibodies successfully treated with antigen-negative platelet transfusions.
    Pappalardo PA, Secord AR, Quitevis P, Haimowitz MD, Goldfinger D.
    Transfusion; 2001 Aug 18; 41(8):984-7. PubMed ID: 11493728
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.